- 全部删除
- 您的购物车当前为空
Bersiporocin是一种新型的脯氨酸-tRNA合成酶(PRS)抑制剂,通过下调胶原蛋白合成发挥抗纤维化作用, 临床中有良好的耐受性。在特发性肺纤维化(IPF)的细胞和动物模型中,DWN12088显著减少了胶原蛋白的合成并改善了肺功能。
Bersiporocin是一种新型的脯氨酸-tRNA合成酶(PRS)抑制剂,通过下调胶原蛋白合成发挥抗纤维化作用, 临床中有良好的耐受性。在特发性肺纤维化(IPF)的细胞和动物模型中,DWN12088显著减少了胶原蛋白的合成并改善了肺功能。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 4,290 | In stock | |
5 mg | ¥ 8,830 | In stock | |
10 mg | ¥ 11,900 | In stock |
Bersiporocin 相关产品
产品描述 | Bersiporocin is a novel prolyl-tRNA synthetase (PRS) inhibitor that exerts antifibrotic effects through downregulation of collagen synthesis and is well tolerated in the clinic. In cellular and animal models of idiopathic pulmonary fibrosis (IPF), DWN12088 significantly reduced collagen synthesis and improved lung function. |
靶点活性 | PRS:≤100 nM |
别名 | DWN12088, DWN 12088 |
分子量 | 328.24 |
分子式 | C15H19Cl2N3O |
CAS No. | 2241808-52-4 |
Smiles | C(CC[C@@H]1[C@@H](O)CCCN1)N2C=3C(N=C2)=C(Cl)C(Cl)=CC3 |
密度 | 1.46 g/cm3 (Predicted) |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 100 mg/mL (304.66 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容